Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (13 items missing)
No data available for the selected time periods
in million USD FY '14FY '15
Research and development
0
2
Patent costs
0
0
General and administrative
2
6
Total operating costs and expenses
2
9
Operating loss
-2
-9
Interest income
0
0
Interest expense
0
0
Other income
0
0
Other income (expense), net
0
0
Net loss
-2
-9
Cumulative preferred stock dividends
-1
0
Accretion of discount on Series C preferred stock
0
0
Net loss attributable to common stockholders
-3
-9
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (18 items missing)
No data available for the selected time periods
in million USD FY '14FY '15
Assets
Cash and cash equivalents
3
16
Prepaid expenses
0
0
Total current assets
3
16
Other assets
0
0
Deferred offering costs
0
0
Property and equipment, net
0
0
Total assets
3
16
Liabilities and owners' equity
Accounts payable
1 1083597
1 739357
Accrued expenses
0 168635
1 614141
Other liablities
0 2518
0 1223
Total current liabilities
1 1254750
1 1354721
Preferred stock subject to redemption
16 16203612
0 0
Preferred stock
0 8888
0 0
Common stock
0 465
0 8582
Additional paid-in capital
3 3399924
42 41759355
Accumulated deficit
-18 -17904319
-27 -27082942
Total stockholders’ equity (deficit)
-14 -14495042
15 14684995
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
3 2963320
16 16039716
Remarks restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (28 items missing)
No data available for the selected time periods
in million USD FY '14FY '15
Net loss
-2
-9
Depreciation
0
0
Stock-based compensation
1
3
Gain on disposal of equipment
0
0
Issuance of shares of common stock to supplier
0
0
Accretion of debt discount
0
0
Non-cash interest on conversion of debt
0
0
Changes in fair value of put embedded in convertible debt
0
0
Prepaid expenses
0
0
Other assets
0
0
Accounts payable
0
0
Accrued expenses
0
0
Other liabilities
0
0
Net cash used in operating activities
-1
-6
Purchases of property and equipment
0
0
Net cash used in investing activities
0
0
Commissions and issuance costs of initial public offering
0
-2
Proceeds from the issuance of shares from common stock purchase agreement
0
1
Proceeds from exercising of options on common stock
0
0
Proceeds from issuance of shares upon closing of initial public offering
0
20
Deferred offering costs
0
0
Proceeds of borrowing under notes payable
1
0
Repayment of borrowing under note payable
0
0
Net proceeds from issuance of preferred stock subject to redemption and warrants to purchase common stock
3
0
Net cash provided by financing activities
3
19
Net increase in cash and cash equivalents
2
13
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,